Non-insulin-dependent diabetes mellitus in cats and humans

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 19, Issue 8, 1997, Pages 935-944

  Struble, Andrea L ^a,b   Nelson, Richard W ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FELIS CATUS;

EID: 3042994251     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Unger RH, Foster DW: Diabetes mellitus, in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology, ed 8. Philadelphia, WB Saunders Co, 1992, pp 1255-1333.
2. Hairé-Joshu D: Management of Diabetes Mellitus: Perspectives of Care Across the Life Span. St. Louis, Mosby-Year Book, 1992.
3. Nelson RW: Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. JAVMA 203:821-827, 1993.
4. Kirk CA: Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats. Am J Vet Res 54:463-467, 1993.
5. Leahy JL: Natural history of B-cell dysfunction in NIDDM. Diabet Care 13:992-1010, 1990.
6. Johnson KH: Islet amyloid, islet amyloid polypeptide and diabetes mellitus. N Engl J Med 321:513-518, 1989.
7. Nelson RW: Glucose tolerance and insulin response in normal weight and obese cats. Am J Vet Res 51:1357-1362, 1990.
8. Westermark P: Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats is composed of a novel putative polypeptide hormone. Am J Pathol 127:414-417, 1987.
9. Westermark P: Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (noninsulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887-892, 1987.
10. Molina J: Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes 39:260-265, 1990.
11. Kassir AA: Lack of effect of islet amyloid polypeptide in causing insulin resistance in conscious dogs during euglycemic clamp studies. Diabetes 40:998-1004, 1991.
12. Kahn CR, Weir GC: Joslin's Diabetes Mellitus, ed 13. Philadelphia, Lea & Febiger, 1994.
13. Biorge V: Effect of weight gain and subsequent weight loss on glucose tolerance and insulin response in healthy cats. J Vet Intern Med, accepted for publication.
14. Nelson RW: Dietary insoluble fiber and glycemic control of diabetic cats. J Vet Intern Med 8:165, 1994.
15. Krezowski PA: The effect of protein ingestion on the metabolic response to oral glucose in normal individuals. Am J Clin Nutr 44:847, 1986.
16. Henry RR: Protein content of the diabetic diet. Diabet Care 17:1502-1513, 1994.
17. Gerich JE: Oral hypoglycemic agents. N Engl J Med 321: 1231-1245, 1989.
18. Miller AB: Effect of glipizide on serum insulin and glucose concentrations in healthy cats. Res Vet Sci 52:177-181, 1992.
19. Klip A, Leiter LA: Cellular mechanism of action of metformin. Diabet Care 13:696-704, 1990.
20. Lebovitz HE: Oral hypoglycemic agents, in Rifkin H, Porte D (eds): Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice, ed 4. New York, Elsevier, 1990, pp 554-574.
21. Groop LC: Sulfonylureas in NIDDM. Diabet Care 15: 737-754, 1992.
22. Rains SC: The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med 5: 653-658, 1988.
23. Bailey CJ, Nattrass M: Treatment - Metformin. Clin Endocrinol Metab 2:455-476, 1988.
24. Brichard SM: Long-term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 125:2510-2516, 1989.
25. Heyliger CE: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227:1474-1477, 1985.
26. Plotnick AN: Oral vanadium compounds: Preliminary studies on toxicity in normal cats and hypoglycemic potential in diabetic cats. J Vet Intern Med 9:181, 1995.
27. Kobayashi M: Effects of thiazolidinediones in diabetes mellitus: Current status and future role. Proc Thiazolid Treat Insul Resist NIDDM:16, 1996.